Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2025-12-24 @ 5:23 PM
NCT ID:
NCT06234150
Eligibility Criteria:
Inclusion Criteria:
* 18-65 years old
* Newly diagnosed, histologically confirmed, resected stage I-IIIa BC
* Scheduled for chemotherapy with Epirubicin+ Cyclophosphamide (EC) regimen
* Presence of objective cognitive decline
Exclusion Criteria:
* Regular exercise habits (exercise at moderate intensity for 30 minutes a day, 3 days a week, for at least 3 months.),
* Motor dysfunction
* Alzheimer's disease
* Vascular dementia
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06234150
Study Brief:
Protocol Section:
NCT06234150